Nov. 27, 2006 – Rozerem that has been eventually approved by the FDA has shown great results upon the people suffering from insomnia. Before this medicine was approved, other sleeping pills used to have narcotic effects whereby gradually it was reduced with sleeping pills such as Ambien, Lunesta, and Sonata.
Rozerem is found to be the first and only medication prescription for use of insomnia in adults. It is prescribed for the treatment of insomnia with symptoms of difficulty in sleep onset. Rozerem can be prescribed for long-term use because the medication does not shows any evidence of abuse or dependence according to sources.
Rozerem has been found different from other sleep drugs and it targets specific switches of the parts of the brain regulating sleep and thereby flipping these switches called melatonin receptors- Rozerem take the brakes of the natural drives of the body.
“In people who sleep normally, the pineal gland in the brain responds to darkness by producing a hormone called melatonin,” Mini says. “This natural melatonin dampens the alerting signal so the sleep load overrides [the waking drive] and allows a person to fall asleep.”
Unlike melatonin, which has widespread effects throughout the body, Rozerem sends two specific melatonin-like signals to the brains sleep center. This reduces the alerting signal at the time a person wants to go to sleep.
Rozerem should be taken within 30 minutes before going to bed. It should not be taken with or immediately after a high-fat meal. Engaging in hazardous activities that require concentration (such as operating motor vehicle or heavy machinery) after taking Rozerem should be avoided.
The most common side effects seen with Rozerem were somnolence, dizziness, and fatigue. Rozerem should not be used in people with severe liver abnormalities.
So would not over-the-counter melatonin supplements work as well as Rozerem? No, Mini says. Rozerem has a more potent effect on the sleep center of the brain than melatonin supplements. And unlike the supplement, Rozerem has been tested in well-designed studies.
“If you look at the melatonin data, and the recent NIH consensus panel statement, it says that there is little evidence to support the use of melatonin for the treatment of insomnia,” Mini says. “And even at that, the dose needed for sleep promotion is unclear. Strict clinical trials of melatonin have not been done. It is an unregulated supplement.”
Please visit our website http://www.benzer11.com/rozerem.html to know more about rozerem medicine and other approved prescriptions.
— End —